Logotipo do repositório
 

Publicação:
Is 44-hour better than 24-hour ambulatory blood pressure monitoring in hemodialysis?

dc.contributor.authorMartin, Luis Cuadrado [UNESP]
dc.contributor.authorFranco, Roberto Jorge da Silva [UNESP]
dc.contributor.authorGavras, I.
dc.contributor.authorMatsubara, Beatriz Bojikian [UNESP]
dc.contributor.authorOkoshi, Katashi [UNESP]
dc.contributor.authorZanati, S. G. [UNESP]
dc.contributor.authorCaramori, J. T. [UNESP]
dc.contributor.authorBarretti, Pasqual [UNESP]
dc.contributor.authorBalbi, André Luis [UNESP]
dc.contributor.authorGavras, H.
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionSchool of Medicine
dc.date.accessioned2014-05-27T11:22:03Z
dc.date.available2014-05-27T11:22:03Z
dc.date.issued2006-12-01
dc.description.abstractThe aim of this study is to evaluate if hemodialysis (HD) patients with similar blood pressure (BP) in the whole inter-HD period could have different target organ lesions and survival if the behavior of BP differs from the first to the second day of the inter-HD period. The present study compares 44-hour ambulatory BP monitoring (ABPM) patterns in 45 HD patients. Three BP patterns emerged: group A (n = 15) had similar BPs throughout (138 ± 11/88 ± 12 in the first 22 h vs. 140 ± 11/87 ± 12 mm Hg in the second 22-hour period); group B (n = 15) had a significant systolic BP rise from the first to the second period (132 ± 15/80 ± 12 vs. 147 ± 12/86 ± 13 mm Hg, p < 0.05); group C (n = 15) had significantly higher BPs (p < 0.05) than the other 2 groups throughout the whole inter-HD period, with no significant change between the 2 halves (172 ± 14/108 ± 12 vs. 173 ± 18/109 ± 14 mm Hg). Ventricular mass and survival during the 30-month follow-up period were statistically significantly better in group A, intermediate in group B and worse in group C. The data suggest that a 44-hour ABPM is more accurate than a 24-hour one in evaluating organ lesion and prognosis in HD patients. Copyright © 2006 S. Karger AG.en
dc.description.affiliationDivision of Nephrology Botucatu Medical School, Botucatu
dc.description.affiliationDivision of Cardiology Department of Internal Medicine Botucatu Medical School, Botucatu
dc.description.affiliationHypertension and Atherosclerosis Section Boston University School of Medicine, Boston, MA
dc.description.affiliationDepartment of Internal Medicine Botucatu Medical School, PO Box 584, Rubiao Junior, Botucatu 18618-000, SP
dc.description.affiliationUnespDivision of Nephrology Botucatu Medical School, Botucatu
dc.description.affiliationUnespDivision of Cardiology Department of Internal Medicine Botucatu Medical School, Botucatu
dc.description.affiliationUnespDepartment of Internal Medicine Botucatu Medical School, PO Box 584, Rubiao Junior, Botucatu 18618-000, SP
dc.format.extent273-279
dc.identifierhttp://dx.doi.org/10.1159/000096176
dc.identifier.citationKidney and Blood Pressure Research, v. 29, n. 5, p. 273-279, 2006.
dc.identifier.doi10.1159/000096176
dc.identifier.issn1420-4096
dc.identifier.lattes7095933557855151
dc.identifier.lattes6990977122340795
dc.identifier.lattes1590971576309420
dc.identifier.lattes5496411983893479
dc.identifier.lattes5697804493071661
dc.identifier.lattes4923203168446615
dc.identifier.orcid0000-0003-4979-4836
dc.identifier.scopus2-s2.0-33845923869
dc.identifier.urihttp://hdl.handle.net/11449/69272
dc.language.isoeng
dc.relation.ispartofKidney and Blood Pressure Research
dc.relation.ispartofjcr3.000
dc.relation.ispartofsjr0,540
dc.rights.accessRightsAcesso restrito
dc.sourceScopus
dc.subjectAmbulatory blood pressure monitoring
dc.subjectHemodialysis
dc.subjectLeft ventricular hypertrophy
dc.subjectantihypertensive agent
dc.subjectcalcitriol
dc.subjecterythropoietin
dc.subjectadult
dc.subjectanuria
dc.subjectblood pressure monitoring
dc.subjectclinical article
dc.subjectcontrolled study
dc.subjectfemale
dc.subjectfollow up
dc.subjectheart left ventricle
dc.subjectheart left ventricle hypertrophy
dc.subjectheart ventricle
dc.subjectheart ventricle volume
dc.subjecthemodialysis
dc.subjecthuman
dc.subjecthypertension
dc.subjectmale
dc.subjectpriority journal
dc.subjectprognosis
dc.subjectstatistical significance
dc.subjectsurvival rate
dc.subjectsystolic blood pressure
dc.subjecttreatment duration
dc.subjectAdult
dc.subjectAged
dc.subjectAlgorithms
dc.subjectAntihypertensive Agents
dc.subjectBlood Pressure Monitoring, Ambulatory
dc.subjectEcho-Planar Imaging
dc.subjectElectrocardiography
dc.subjectFemale
dc.subjectHeart Rate
dc.subjectHumans
dc.subjectHypertension
dc.subjectKidney Failure, Chronic
dc.subjectKidney Function Tests
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectRenal Dialysis
dc.subjectSurvival Analysis
dc.titleIs 44-hour better than 24-hour ambulatory blood pressure monitoring in hemodialysis?en
dc.typeArtigo
dcterms.licensehttp://www.karger.com/Services/RightsPermissions
dspace.entity.typePublication
unesp.author.lattes5496411983893479[8]
unesp.author.lattes7095933557855151
unesp.author.lattes6990977122340795
unesp.author.lattes1590971576309420
unesp.author.lattes5697804493071661[9]
unesp.author.lattes4923203168446615
unesp.author.orcid0000-0002-0607-8189[6]
unesp.author.orcid0000-0003-4979-4836[8]
unesp.author.orcid0000-0001-8366-5064[9]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt
unesp.departmentClínica Médica - FMBpt

Arquivos